Kenvue Inc. $KVUE Shares Acquired by Athos Capital Ltd

Athos Capital Ltd increased its position in shares of Kenvue Inc. (NYSE:KVUE) by 38.3% in the 4th quarter, HoldingsChannel.com reports. The firm owned 3,457,749 shares of the company’s stock after purchasing an additional 957,749 shares during the quarter. Kenvue comprises approximately 23.0% of Athos Capital Ltd’s portfolio, making the stock its biggest holding. Athos Capital Ltd’s holdings in Kenvue were worth $59,646,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in the company. Aberdeen Group plc lifted its holdings in shares of Kenvue by 84.1% in the third quarter. Aberdeen Group plc now owns 1,411,380 shares of the company’s stock worth $22,914,000 after acquiring an additional 644,930 shares during the last quarter. Oak Thistle LLC bought a new position in shares of Kenvue in the fourth quarter worth about $1,563,000. Eubel Brady & Suttman Asset Management Inc. lifted its holdings in shares of Kenvue by 39.7% in the third quarter. Eubel Brady & Suttman Asset Management Inc. now owns 1,371,886 shares of the company’s stock worth $22,266,000 after acquiring an additional 389,704 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its holdings in shares of Kenvue by 25.8% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 410,874 shares of the company’s stock worth $7,088,000 after acquiring an additional 84,219 shares during the last quarter. Finally, SG Americas Securities LLC increased its stake in shares of Kenvue by 3,889.9% in the fourth quarter. SG Americas Securities LLC now owns 3,075,723 shares of the company’s stock valued at $53,056,000 after buying an additional 2,998,635 shares during the period. 97.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on KVUE shares. Canaccord Genuity Group upped their price objective on Kenvue from $17.00 to $18.00 and gave the company a “hold” rating in a research note on Wednesday, February 18th. Barclays lowered their price objective on Kenvue from $19.00 to $18.00 and set an “equal weight” rating for the company in a research note on Tuesday, April 14th. Zacks Research raised Kenvue from a “hold” rating to a “strong-buy” rating in a research note on Friday, May 8th. Weiss Ratings downgraded Kenvue from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, May 29th. Finally, Citigroup lowered their price objective on Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a research note on Wednesday, April 15th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and twelve have given a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $19.33.

Kenvue Stock Performance

Kenvue stock opened at $18.08 on Friday. The business has a 50 day moving average of $17.41 and a 200-day moving average of $17.53. Kenvue Inc. has a 1 year low of $14.02 and a 1 year high of $22.87. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.98 and a quick ratio of 0.70. The company has a market capitalization of $34.70 billion, a P/E ratio of 21.26, a P/E/G ratio of 1.37 and a beta of 0.54.

Kenvue (NYSE:KVUE) last released its earnings results on Thursday, May 7th. The company reported $0.32 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05. The business had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $3.84 billion. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The company’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.24 EPS. On average, equities research analysts predict that Kenvue Inc. will post 1.16 earnings per share for the current year.

Kenvue Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, May 27th. Shareholders of record on Wednesday, May 13th were given a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a yield of 4.6%. The ex-dividend date of this dividend was Wednesday, May 13th. Kenvue’s dividend payout ratio is currently 97.65%.

Insiders Place Their Bets

In other Kenvue news, General Counsel Matthew Orlando sold 38,491 shares of the stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $17.66, for a total transaction of $679,751.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.59% of the company’s stock.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.